SCHEMBL4350039

SCHEMBL4350039

Cc1cc(F)c(F)c(N=C=S)c1F

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1457358 0.85 GABRA1 (0.34) GABRA1GABRB2
SCHEMBL1996913 0.80 CYP3A4 (0.36) GABRA1GABRB2
SCHEMBL17322553 0.73 GABRA1 (0.31) GABRA1GABRB2
SCHEMBL25573712 0.72 GABRA1 (0.36) GABRA1GABRB2
SCHEMBL24390818 0.72 RAPGEF4 (0.33) GABRA1GABRB2
SCHEMBL4350033 0.72 GABRA1 (0.33) GABRA1GABRB2
SCHEMBL17650996 0.72 GABRA1 (0.33) GABRA1GABRB2
SCHEMBL15589318 0.71 ALDH1A1 (0.38)
SCHEMBL125198 0.70 GABRA1 (0.34) GABRA1GABRB2
SCHEMBL10326019 0.70 GABRA1 (0.38) GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094677-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES NV Remynd (BE) 2009-09-02 EP disclosed
WO-2008061781-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES NV REMYND (BE) 2008-05-29 WO disclosed